Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | TDP2 | O95551 | 1/20 | 0.37 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31555987 | 0.77 | MAOA (0.41) | MAOAALDH1A1MAPTKDM4EPOLB | |
| SCHEMBL2324941 | 0.76 | — | — | |
| SCHEMBL21853792 | 0.68 | ALDH1A1 (0.38) | MAOAALDH1A1MAPTKDM4EPOLB | |
| SCHEMBL8487541 | 0.67 | ALDH1A1 (0.46) | MAOAALDH1A1MAPTKDM4EPOLB | |
| SCHEMBL8487542 | 0.67 | MAOA (0.46) | MAOAALDH1A1MAPTKDM4EPOLB | |
| SCHEMBL18721774 | 0.67 | MAOA (0.46) | MAOAALDH1A1MAPTKDM4EPOLB | |
| SCHEMBL7648836 | 0.67 | ALDH1A1 (0.46) | MAOAALDH1A1MAPTKDM4EPOLB | |
| SCHEMBL15630156 | 0.65 | — | — | |
| SCHEMBL2691041 | 0.64 | — | — | |
| SCHEMBL11934162 | 0.63 | MAOA (0.43) | MAOAALDH1A1MAPTKDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2122 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4395831-A1 | COMPOSITIONS AND METHODS FOR SKIPPING EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY | Entrada Therapeutics, Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| EP-4395829-A1 | COMPOUNDS AND METHODS FOR SKIPPING EXON 44 IN DUCHENNE MUSCULAR DYSTROPHY | Entrada Therapeutics, Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| CN-118284434-A | Compositions and methods for skipping exon 45 in duchenne muscular dystrophy | 恩特拉达治疗学股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118215504-A | Compounds and methods for skipping exon 44 in duchenne muscular dystrophy | 恩特拉达治疗学股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| EP-4359006-A1 | ANTISENSE COMPOUNDS AND METHODS FOR TARGETING CUG REPEATS | Entrada Therapeutics, Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| CN-117957022-A | Antisense compounds and methods for targeting CUG repeats | 安卓达治疗股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117915957-A | Compositions and methods for modulating mRNA splicing | 恩特拉达治疗学股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117897176-A | Compositions and methods for modulating tissue distribution of intracellular therapeutic agents | 恩特拉达治疗学股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| EP-4337263-A1 | COMPOSITIONS AND METHODS FOR MODULATING INTERFERON REGULATORY FACTOR-5 (IRF-5) ACTIVITY | Entrada Therapeutics, Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| EP-4337264-A1 | COMPOSITIONS AND METHODS FOR MODULATING TISSUE DISTRIBUTION OF INTRACELLULAR THERAPEUTICS | Entrada Therapeutics, Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| US-6664230-B1 | Amino acid sequence 5 having at least one dextro residue; retains biological activity; elevated serum halflife | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2003-12-16 | — | — | US | claimed |
| US-6586187-B1 | 2-benzyloxycarbonylamino-3-(2-(4-(2-(3-benzylureido)-ethyl) -piperazin-1-yl)acetylamino)-propionic acid, for example; method of synthesis using Wang resins; various uses including anticancer, antiinflammatory and antiviral agents | WYETH | 2003-07-01 | — | — | US | claimed |
| EP-1255542-A1 | SUBSTITUTED AMINO ACIDS AS NEUTRAL SPHINGOMYELINASE INHIBITORS | Ortho-Mcneil Pharmaceutical, Inc. (US) | 2002-11-13 | — | — | EP | claimed |
| US-20020016350-A1 | Substituted amino acids as erythropoietin mimetics | CONNOLLY PETER J (US) | 2002-02-07 | — | — | US | claimed |
| US-6310078-B1 | MODULATING ERYTHROPOIETIN RECEPTOR, TREATING DISEASE OR CONDITION MEDIATED BY SAID RECEPTOR | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2001-10-30 | — | — | US | claimed |
| US-6306911-B1 | ENZYME INHIBITORS | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2001-10-23 | — | — | US | claimed |
| WO-2001056560-A1 | SUBSTITUTED AMINO ACIDS AS NEUTRAL SPHINGOMYELINASE INHIBITORS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-08-09 | — | — | WO | claimed |
| EP-1073623-A1 | SUBSTITUTED AMINO ACIDS AS ERYTHROPOIETIN MIMETICS | Ortho-Mcneil Pharmaceutical, Inc. (US) | 2001-02-07 | — | — | EP | claimed |
| WO-2000061545-A1 | METHODS FOR SOLID PHASE COMBINATORIAL SYNTHESIS OF INTEGRIN INHIBITORS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-10-19 | — | — | WO | claimed |
| WO-1999054279-A1 | SUBSTITUTED AMINO ACIDS AS ERYTHROPOIETIN MIMETICS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 1999-10-28 | — | — | WO | claimed |